49. Systemic lupus erythematosus Clinical trials / Disease details
Clinical trials : 993 / Drugs : 702 - (DrugBank : 184) / Drug target genes : 116 - Drug target pathways : 200
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01269866 (ClinicalTrials.gov) | December 2010 | 3/1/2011 | Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus Erythematosus | Duloxetine (Cymbalta) in the Reduction of Pain Severity in Patient With Systemic Lupus Erythematosus: A Pilot Study | Systemic Lupus Erythematosus | Drug: Cymbalta | Dr. Jesus Gutierrez Stone | NULL | Completed | 18 Years | 65 Years | Both | 26 | N/A | United States |